The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer.
about
The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The anti-ErbB2 antibody H2-18 ...... -overexpressing breast cancer.
@en
type
label
The anti-ErbB2 antibody H2-18 ...... -overexpressing breast cancer.
@en
prefLabel
The anti-ErbB2 antibody H2-18 ...... -overexpressing breast cancer.
@en
P2093
P2860
P356
P1433
P1476
The anti-ErbB2 antibody H2-18 ...... -overexpressing breast cancer.
@en
P2093
Beibei Liang
Chaohua Hu
Huafeng Wei
Huajing Wang
Lingfei Wang
Shujun Pan
P2860
P304
52877-52888
P356
10.18632/ONCOTARGET.17907
P407
P577
2017-05-16T00:00:00Z